Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
{{familytree | | | | |!| | | | | | | | | | | | |!| | | }} | {{familytree | | | | |!| | | | | | | | | | | | |!| | | }} | ||
{{familytree | |,|-|-|+|-|-|.| | | | | | | |,|-|^|-|.| | }} | {{familytree | |,|-|-|+|-|-|.| | | | | | | |,|-|^|-|.| | }} | ||
{{familytree | F01 | {{familytree | F01 | F02 | | F03 | | | | | | | | F04 | | | F05 | | |F01=bone|F02=Ing|F03=Supra|F04=dasd|F05=asd}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 19:28, 10 October 2018
| Tumor of unknown primary origin | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| • Full medical history and physical exam • Basic blood and bichemical analysis • CT scan of chest, abdomen, and pelvis | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Histopathologic examination | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Squamous cell carcinoma | Neuroendocrine carcinoma | Adenocarcinoma and poorly differntiated carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Additional tests specific to location of metastasis | • Octreoscan • Plasma chromogranin A | Gender specific tests | |||||||||||||||||||||||||||||||||||||||||||||||||||
| bone | Ing | Supra | dasd | asd | |||||||||||||||||||||||||||||||||||||||||||||||||